BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34530776)

  • 21. Association between serum prostate-specific antigen level, liver function tests and lipid profile in healthy men.
    Han JH; Chang IH; Ahn SH; Kwon OJ; Bang SH; Choi NY; Park SW; Myung SC; Kim HW
    BJU Int; 2008 Nov; 102(9):1097-101. PubMed ID: 18522630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigating the prostate specific antigen, body mass index and age relationship: is an age-BMI-adjusted PSA model clinically useful?
    Harrison S; Tilling K; Turner EL; Lane JA; Simpkin A; Davis M; Donovan J; Hamdy FC; Neal DE; Martin RM
    Cancer Causes Control; 2016 Dec; 27(12):1465-1474. PubMed ID: 27830401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Value of prostate-specific antigen (PSA) mass ratio in the detection of prostate cancer in men with PSA levels of ≤10 ng/mL.
    Hong SK; Oh JJ; Byun SS; Hwang SI; Choo MS; Lee SE
    BJU Int; 2012 Jul; 110(2 Pt 2):E81-5. PubMed ID: 22093144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between obesity, prostate-specific antigen level and prostate-specific antigen density in men with a negative prostate biopsy.
    Kim JH; Lee SW; Kim JH; Yang HJ; Doo SW; Yoon JH; Kim DS; Yang WJ; Lee KW; Kim JM; Lee C; Kwon SS
    J Int Med Res; 2014 Jun; 42(3):821-7. PubMed ID: 24743874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of High Body Mass Index With More Advanced Localized Prostate Cancer at Radical Prostatectomy Is Not Reflected in PSA Level and PSA Density but Is Seen in PSA Mass.
    Kryvenko ON; Epstein JI; Meier FA; Gupta NS; Menon M; Diaz M
    Am J Clin Pathol; 2015 Aug; 144(2):271-7. PubMed ID: 26185312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Actual lowering effect of metabolic syndrome on serum prostate-specific antigen levels is partly concealed by enlarged prostate: results from a large-scale population-based study.
    Zhao S; Xia M; Tang J; Yan Y
    BJU Int; 2017 Oct; 120(4):482-489. PubMed ID: 27489082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does body mass index "dilute" the predictive property of prostate-specific antigen for tumor volume at radical prostatectomy?
    Mitchell CR; Umbreit EC; Rangel LJ; Bergstralh EJ; Karnes RJ
    Urology; 2011 Oct; 78(4):868-72. PubMed ID: 21843902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate-specific antigen as an estimator of prostate volume in the management of patients with symptomatic benign prostatic hyperplasia.
    Mochtar CA; Kiemeney LA; van Riemsdijk MM; Barnett GS; Laguna MP; Debruyne FM; de la Rosette JJ
    Eur Urol; 2003 Dec; 44(6):695-700. PubMed ID: 14644122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of body mass index on prostate volume and prostate-specific antigen in men over 50: A cross-sectional study.
    Zaza MM; Salem TA; Hassanin ISF; Soliman MHA
    Urologia; 2023 May; 90(2):224-229. PubMed ID: 37039389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening.
    Hutterer G; Perrotte P; Gallina A; Walz J; Jeldres C; Traumann M; Suardi N; Saad F; Bénard F; Valiquette L; McCormack M; Graefen M; Montorsi F; Karakiewicz PI
    Eur J Cancer; 2007 May; 43(7):1180-7. PubMed ID: 17292604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Body mass index and prostate specific antigen levels in Jamaican men.
    Tulloch-Reid MK; Aiken WD; Morrison BF; Tulloch T; Mayhew R; Wan RL; Bennett FI; Coard KC; Jackson MD
    West Indian Med J; 2011 Jun; 60(3):316-21. PubMed ID: 22224345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostatic volume and volume-adjusted prostate-specific antigen as predictive parameters for T1c prostate cancer.
    Tanaka N; Fujimoto K; Yoshikawa M; Tanaka M; Hirao Y; Kondo H; Saito I
    Hinyokika Kiyo; 2007 Jul; 53(7):459-65. PubMed ID: 17702178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate health index (PHI) and prostate-specific antigen (PSA) predictive models for prostate cancer in the Chinese population and the role of digital rectal examination-estimated prostate volume.
    Chiu PK; Roobol MJ; Teoh JY; Lee WM; Yip SY; Hou SM; Bangma CH; Ng CF
    Int Urol Nephrol; 2016 Oct; 48(10):1631-7. PubMed ID: 27349564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate-specific Antigen Mass Density--A Measure Predicting Prostate Cancer Volume and Accounting for Overweight and Obesity-related Prostate-specific Antigen Hemodilution.
    Kryvenko ON; Diaz M; Matoso A; Kates M; Cohen J; Swanson GP; Epstein JI
    Urology; 2016 Apr; 90():141-7. PubMed ID: 26773349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between insulin resistance, obesity and serum prostate-specific antigen levels in healthy men.
    Han JH; Lee YT; Kwak KW; Ahn SH; Chang IH; Myung SC; Oh SY; Lee YS; Kim W; Jin YW; Choi TI; Sung SH
    Asian J Androl; 2010 May; 12(3):400-4. PubMed ID: 20305674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations of demographic and lifestyle characteristics with prostate-specific antigen (PSA) concentration and rate of PSA increase.
    Kristal AR; Chi C; Tangen CM; Goodman PJ; Etzioni R; Thompson IM
    Cancer; 2006 Jan; 106(2):320-8. PubMed ID: 16342294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of anthropometric measurements, age, and prostate volume on prostate-specific antigen levels in men with a low risk of prostate cancer.
    Ochiai A; Fritsche HA; Babaian RJ
    Urology; 2005 Oct; 66(4):819-23. PubMed ID: 16230145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.
    Freedland SJ; Sun L; Kane CJ; Presti JC; Terris MK; Amling CL; Moul JW; Aronson WJ
    BJU Int; 2008 Sep; 102(8):969-74. PubMed ID: 18691175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Obesity and prostate cancer detection: insights from three national surveys.
    Parekh N; Lin Y; Dipaola RS; Marcella S; Lu-Yao G
    Am J Med; 2010 Sep; 123(9):829-35. PubMed ID: 20800152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does obesity affect the accuracy of prostate-specific antigen (PSA) for predicting prostate cancer among men undergoing prostate biopsy.
    Oh JJ; Jeong SJ; Lee BK; Jeong CW; Byun SS; Hong SK; Lee SE
    BJU Int; 2013 Aug; 112(4):E265-71. PubMed ID: 23432960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.